Long COVID and ME/CFS: What Are the Most Promising Medical Treatments in 2026?

If you've been living with Long COVID or Long COVID that has developed into an ME/CFS-like illness, you've probably asked the same question countless times:

"Is there finally a treatment that works?"

The honest answer is not yet—but we are closer than we've ever been.

Only a few years ago, doctors knew very little about Long COVID. Today, researchers have identified several biological abnormalities that may contribute to symptoms, including persistent immune activation, autonomic nervous system dysfunction, viral persistence, mitochondrial dysfunction, abnormalities in blood flow, and chronic inflammation.

This has transformed the search for treatments. Instead of looking for one miracle cure, researchers are testing therapies that target the different biological processes that may be driving symptoms in different groups of patients.

The Most Promising Medical Treatments

1. Low-Dose Naltrexone (LDN)

One of the most talked-about treatments is low-dose naltrexone (LDN).

Originally developed to treat opioid addiction at much higher doses, LDN appears to have very different effects when used at doses between 1 and 4.5 mg.

Researchers believe it may:

• reduce neuroinflammation

• calm overactive immune cells (microglia)

• reduce pain

• improve fatigue

• improve cognitive symptoms in some people.

  
  

Small clinical studies and case series have reported improvements in fatigue, pain and quality of life, and many Long COVID and ME/CFS clinics now prescribe LDN off-label. However, larger randomised controlled trials are still underway, so it cannot yet be considered a proven treatment.

2. Treatments for POTS and Autonomic Dysfunction

Many people with Long COVID actually feel better once their autonomic nervous system problems are recognised and treated.

Medications commonly used include:

• beta-blockers

• ivabradine

• fludrocortisone

• midodrine.

  
  

These medications do not treat Long COVID itself, but they can significantly improve symptoms such as:

• dizziness

• racing heart

• brain fog

• fatigue when standing

• palpitations.

  
  

Combined with increased fluids, salt (where appropriate) and compression garments, these treatments can dramatically improve day-to-day functioning.

3. Antihistamines

Some patients appear to have symptoms consistent with mast cell activation or excessive histamine release.

Although the evidence is still limited, some people report improvements in:

• itching

• flushing

• gastrointestinal symptoms

• brain fog

• fatigue

using combinations of H1 and H2 antihistamines.

Researchers are still trying to identify which patients are most likely to benefit.

4. Antiviral Drugs

One of the leading theories is that fragments of the SARS-CoV-2 virus may persist in some people, continuing to stimulate the immune system.

This has led researchers to investigate antiviral medications.

So far, results have been mixed. Current evidence does not support the routine use of antivirals such as nirmatrelvir/ritonavir (Paxlovid) for people with established Long COVID, although antivirals given during the acute COVID-19 infection may reduce the risk of developing Long COVID in some higher-risk groups.

Researchers continue to investigate whether different antivirals, longer treatment courses or selecting patients with evidence of viral persistence could produce better results.

5. Immune-Modulating Therapies

Scientists increasingly recognise that Long COVID may involve an immune system that remains switched on long after the initial infection.

Several drugs that modify the immune response are now being studied, including:

• JAK inhibitors

• monoclonal antibodies

• drugs that reduce inflammation

• treatments targeting autoimmune mechanisms.

These treatments remain experimental but are among the most exciting areas of current research.

6. Mitochondrial Support

Many studies have demonstrated abnormalities in energy production within the mitochondria.

Although no medication currently reverses this problem, researchers are investigating therapies that improve:

• cellular energy production

• oxidative stress

• oxygen utilisation

• metabolic flexibility.

Some clinicians also recommend supplements such as Coenzyme Q10, acetyl-L-carnitine, riboflavin or creatine, but evidence remains limited and these should be viewed as supportive rather than curative.

Treatments to Approach with Caution

Living with a chronic illness often means being exposed to endless claims of miracle cures. While it is natural to want to try everything, some approaches deserve particular caution.

Graded Exercise Therapy (GET)

If your Long COVID includes post-exertional symptom exacerbation (PESE) or you have developed an ME/CFS-like illness, programmes that encourage you to steadily increase exercise regardless of symptoms can make you worse.

Current international guidance recommends that rehabilitation should be individualised and that PESE should be identified before increasing exercise.

Pushing Through Fatigue

Many people are told they simply need to "build up their fitness."

Unfortunately, PESE is not caused by being unfit. Repeatedly exceeding your energy limits may lead to prolonged crashes lasting days or weeks.

Expensive Experimental Treatments

Private clinics may offer treatments such as:

• stem cell therapy

• plasmapheresis

• ozone therapy

• high-cost immune infusions.

At present, there is insufficient high-quality evidence to recommend these routinely, and many are expensive with uncertain benefits.

Hyperbaric Oxygen Therapy

Hyperbaric oxygen therapy has shown encouraging results in some small studies, particularly for fatigue and cognition. However, the studies have generally been small, and larger clinical trials are needed before it can be recommended as a standard treatment.

Extreme Diets and Detox Programmes

There is no convincing evidence that restrictive detoxes, prolonged fasting or expensive supplement "protocols" cure Long COVID.

A nutritious, anti-inflammatory type diet is far more likely to support recovery than highly restrictive approaches that increase the risk of nutritional deficiencies.

Why Recovery Looks Different for Everyone

One reason Long COVID has been so difficult to treat is that it probably isn't a single disease.

Researchers increasingly believe there are several biological "subtypes" or endotypes, including people whose symptoms are driven predominantly by:

• viral persistence

• immune dysregulation

• autonomic dysfunction

• endothelial and microvascular dysfunction

• mitochondrial dysfunction

• mast cell activation.

This helps explain why one person may improve with LDN while another responds better to treatment for POTS or antihistamines.

In the future, doctors are likely to use blood tests and biomarkers to identify which biological pathway is most active in each patient, allowing treatments to be tailored far more precisely.

Reasons to Feel Hopeful

Although progress sometimes feels frustratingly slow, the pace of research has been extraordinary.

Thousands of researchers around the world are now working to understand Long COVID, and large international trials are evaluating antiviral drugs, immune-modulating therapies, treatments for autonomic dysfunction and medicines that target inflammation and cellular energy production.

Perhaps the most encouraging development is that researchers no longer see Long COVID as simply "post-viral fatigue." It is increasingly recognised as a complex biological illness with identifiable abnormalities affecting multiple body systems. This shift has accelerated research into biomarkers and precision medicine, bringing us closer to treatments tailored to the biology of each individual rather than a one-size-fits-all approach.

For those living with both Long COVID and ME/CFS, this is especially significant. The overlap between these conditions has led to greater investment in understanding post-viral illnesses as a whole, and discoveries in one condition are already informing the other.

While there is still no universal cure, there is far more reason for optimism today than there was just a few years ago. Every clinical trial, every new biomarker and every improvement in our understanding brings us one step closer to treatments that are not only effective but targeted to the people most likely to benefit.

Key Take-Home Messages

• There is currently no single proven cure for Long COVID or ME/CFS.

• Low-dose naltrexone, treatments for POTS and selected antihistamines are among the most promising symptom-directed therapies, but more research is needed.

• Antiviral and immune-modulating drugs remain under active investigation, with personalised approaches likely to be the future.

• If you experience post-exertional symptom exacerbation, avoid programmes that encourage you to push through fatigue or progressively increase exercise regardless of symptoms.

• Recovery varies because Long COVID probably consists of several different biological subtypes rather than one single illness.

• The pace of research is accelerating, and the next few years are likely to bring more targeted and effective treatments.

Bibliography

• European Respiratory Society Clinical Practice Guideline for Long COVID (2026).

• Davis HE, McCorkell L, Vogel JM, et al. Long COVID: major findings, mechanisms and recommendations. Nature Reviews (review articles on pathophysiology and management).

• Altmann DM, Whettlock EM, Liu S, et al. Immunology of Long COVID. Nature Reviews Immunology. (abstract only)

• RECOVER Initiative publications on Long COVID treatment trials and phenotyping.

• NICE Guideline NG188: COVID-19 rapid guideline: managing the long-term effects of COVID-19 (regularly updated).